Building a microphysiological skin model from induced pluripotent stem cells

Stem Cell Research and Therapy

Volumn 4, Issue SUPPL.1, 2013, Pages

  Guo, Zongyou ^a   Higgins, Claire A ^a   Gillette, Brian M ^b   Itoh, Munenari ^a   Umegaki, Noriko ^a   Gledhill, Karl ^a   Sia, Samuel K ^b   Christiano, Angela M ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Earth and Environmental Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ANATOMIC MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG DEVELOPMENT; DRUG INTERACTION; DRUG SCREENING; FIBROBLAST; GENE EXPRESSION; GENOMIC INSTABILITY; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SKIN DISCOLORATION; SKIN DRUG INTERACTION; SKIN MANIFESTATION; SKIN MODEL; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CELL DIFFERENTIATION; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KERATINOCYTES; MELANOCYTES; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN, ARTIFICIAL;

EID: 84891368960     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt363     Document Type: Review

References (67)

1. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL, Nat Rev Drug Discov 2010 9 203 214 20168317
2. Artificial skin in perspective: concepts and applications. Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS, Pigment Cell Melanoma Res 2011 24 35 50 10.1111/j.1755-148X.2010.00786.x 21029393
3. Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. Taylor DK, Bubier JA, Silva KA, Sundberg JP, Vet Pathol 2012 49 146 154 10.1177/0300985811430511 22135020
4. Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems. Birgersdotter A, Sandberg R, Ernberg I, Semin Cancer Biol 2005 15 405 412 10.1016/j.semcancer.2005.06.009 16055341 (Pubitemid 41140308)
5. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S, Analyst 2011 136 473 478 10.1039/c0an00609b 20967331
6. Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Stark HJ, Szabowski A, Fusenig NE, Maas-Szabowski N, Biol Proced Online 2004 6 55 60 10.1251/bpo72 15103399 (Pubitemid 38597693)
7. Skin tissue engineering-in vivo and in vitro applications. Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K, Adv Drug Deliv Rev 2011 63 352 366 10.1016/j.addr.2011.01.005 21241756
8. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T, Science 1981 211 1052 1054 10.1126/science.7008197 7008197 (Pubitemid 11131539)
9. Three-dimensional tissue models of normal and diseased skin. Carlson MW, Alt-Holland A, Egles C, Garlick JA, Curr Protoc Cell Biol 2008 Chapter 19 Unit 19 9
10. Establishment of 3D organotypic cultures using human neonatal epidermal cells. Gangatirkar P, Paquet-Fifield S, Li A, Rossi R, Kaur P, Nat Protoc 2007 2 178 186 10.1038/nprot.2006.448 17401352 (Pubitemid 47040081)
11. Transfer of melanosomes in a skin equivalent model in vitro. Topol BM, Haimes HB, Dubertret L, Bell E, J Invest Dermatol 1986 87 642 647 10.1111/1523-1747.ep12456314 3772157 (Pubitemid 17178898)
12. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA, Br J Dermatol 2003 148 1094 1104 10.1046/j.1365-2133.2003.05298.x 12828735 (Pubitemid 36819207)
13. Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells. Bechetoille N, Dezutter-Dambuyant C, Damour O, Andre V, Orly I, Perrier E, Tissue Eng 2007 13 2667 2679 10.1089/ten.2006.0405 17883323 (Pubitemid 350076746)
14. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. Roggenkamp D, Kopnick S, Stab F, Wenck H, Schmelz M, Neufang G, J Invest Dermatol 2013 133 1620 1628 10.1038/jid.2012.464 23283070
15. Progress and opportunities for tissue-engineered skin. MacNeil S, Nature 2007 445 874 880 10.1038/nature05664 17314974
16. Palmoplantar keratoderma associated with congenital heart disease. Hoeger PH, Yates RW, Harper JI, Br J Dermatol 1998 138 506 509 10.1046/j.1365-2133. 1998.02134.x 9580809 (Pubitemid 28145524)
17. Perspective: don't be superficial. Boehncke WH, Nature 2012 492 55 10.1038/492S55a 23254972
18. Psychodermatology: an emotional response. DeWeerdt S, Nature 2012 492 62 S63 10.1038/492S62a 23254976
19. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF, Cell 2011 147 447 458 10.1016/j.cell.2011.08.043 22000021
20. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. Redondo P, de Felipe I, de la Pena A, Aramendia JM, Vanaclocha V, Br J Dermatol 1997 136 645 646 10.1111/j.1365-2133.1997. tb02175.x 9155988 (Pubitemid 27160362)
21. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Gerull R, Nelle M, Schaible T, Crit Care Med 2011 39 1521 1532 10.1097/CCM. 0b013e31821201ed 21358399
22. Severe adverse cutaneous reactions to drugs. Roujeau JC, Stern RS, N Engl J Med 1994 331 1272 1285 10.1056/NEJM199411103311906 7794310 (Pubitemid 24333193)
23. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
24. Generation of induced pluripotent stem cells from human blood. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ, Blood 2009 113 5476 5479 10.1182/blood-2009-02-204800 19299331
25. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins C, Christiano AM, PLOS ONE 2013 8 77673 10.1371/journal.pone.0077673 24147053
26. Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Grskovic M, Javaherian A, Strulovici B, Daley GQ, Nat Rev Drug Discov 2011 10 915 929 22076509
27. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Rowntree RK, McNeish JD, Regen Med 2010 5 557 568 10.2217/rme.10.36 20632859
28. Workshop meeting report Organs-on-Chips: human disease models. van de Stolpe A, den Toonder J, Lab Chip 2013 13 3449 3470 10.1039/c3lc50248a 23645172
29. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ, Nat Biotechnol 2011 29 1117 1119 10.1038/nbt.2052 22119740
30. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR, Nature 2011 471 68 73 10.1038/nature09798 21289626
31. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JC, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF, Cell Stem Cell 2011 8 106 118 10.1016/j.stem.2010.12.003 21211785
32. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM, Chen T, Ooi SS, Kim SY, Bestor TH, Shioda T, Park PJ, Hochedlinger K, Nat Genet 2012 44 398 405 S1-S2 10.1038/ng.1110 22387999
33. Variability in the generation of induced pluripotent stem cells: importance for disease modeling. Vitale AM, Matigian NA, Ravishankar S, Bellette B, Wood SA, Wolvetang EJ, Mackay-Sim A, Stem Cells Transl Med 2012 1 641 650 10.5966/sctm.2012-0043 23197870
34. Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing Puma. Lake BB, Fink J, Klemetsaune L, Fu X, Jeffers JR, Zambetti GP, Xu Y, Stem Cells 2012 30 888 897 10.1002/stem.1054 22311782
35. Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances. Tornier C, Amsellem C, Fraissinette Ade B, Alepee N, Toxicol In Vitro 2010 24 245 256 10.1016/j.tiv.2009.08.023 19733227
36. In vitro models for human skin disease. Semlin L, Schafer-Korting M, Borelli C, Korting HC, Drug Discov Today 2011 16 132 139 10.1016/j.drudis.2010. 12.001 21146629
37. Development of an in vitro psoriatic skin model by tissue engineering. Jean J, Lapointe M, Soucy J, Pouliot R, J Dermatol Sci 2009 53 19 25 10.1016/j.jdermsci.2008.07.009 18783923
38. Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Auxenfans C, Fradette J, Lequeux C, Germain L, Kinikoglu B, Bechetoille N, Braye F, Auger FA, Damour O, Eur J Dermatol 2009 19 107 113 19106039
39. Characterization of a new tissue-engineered human skin equivalent with hair. Michel M, L'Heureux N, Pouliot R, Xu W, Auger FA, Germain L, Vitro Cell Dev Biol Anim 1999 35 318 326 10.1007/s11626-999-0081-x (Pubitemid 29288355)
40. Generation of pluripotent stem cells from patients with type 1 diabetes. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA, Proc Natl Acad Sci USA 2009 106 15768 15773 10.1073/pnas.0906894106 19720998
41. Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. Hewitt KJ, Shamis Y, Hayman RB, Margvelashvili M, Dong S, Carlson MW, Garlick JA, PLoS One 2011 6 17128 10.1371/journal.pone.0017128 21386890
42. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Itoh M, Kiuru M, Cairo MS, Christiano AM, Proc Natl Acad Sci USA 2011 108 8797 8802 10.1073/pnas. 1100332108 21555586
43. Efficient generation of functional epithelial and epidermal cells from human pluripotent stem cells under defined conditions. Selekman JA, Grundl NJ, Kolz JM, Palecek SP, Tissue Eng Part C Methods 2013
44. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Tornier C, Rosdy M, Maibach HI, Toxicol In Vitro 2006 20 401 416 10.1016/j.tiv.2005.09.004 16229985
45. Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. Golden AP, Tien J, Lab Chip 2007 7 720 725 10.1039/b618409j 17538713 (Pubitemid 46848690)
46. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Levenberg S, Ferreira LS, Chen-Konak L, Kraehenbuehl TP, Langer R, Nat Protoc 2010 5 1115 1126 10.1038/nprot.2010.31 20539287
47. Human skin pigmentation: melanocytes modulate skin color in response to stress. Costin GE, Hearing VJ, FASEB J 2007 21 976 994 10.1096/fj.06-6649rev 17242160 (Pubitemid 46495689)
48. The three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progression. Li L, Fukunaga-Kalabis M, Herlyn M, J Vis Exp 2011 54 2937
49. Generation of human melanocytes from induced pluripotent stem cells. Ohta S, Imaizumi Y, Akamatsu W, Okano H, Kawakami Y, Methods Mol Biol 2013 989 193 215 10.1007/978-1-62703-330-5-16 23483397
50. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Sung JH, Esch MB, Prot JM, Long CJ, Smith A, Hickman JJ, Shuler ML, Lab Chip 2013 13 1201 1212 10.1039/c3lc41017j 23388858
51. Microengineered physiological biomimicry: organs-on-chips. Huh D, Torisawa YS, Hamilton GA, Kim HJ, Ingber DE, Lab Chip 2012 12 2156 2164 10.1039/c2lc40089h 22555377
52. Differential expression of matrix metalloproteinase-1 in vitro corresponds to tissue morphogenesis and quality assurance of cultured skin substitutes. Swope VB, Boyce ST, J Surg Res 2005 128 79 86 10.1016/j.jss.2005. 03.018 15936034 (Pubitemid 41188214)
53. Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Stark HJ, Willhauck MJ, Mirancea N, Boehnke K, Nord I, Breitkreutz D, Pavesio A, Boukamp P, Fusenig NE, Eur J Cell Biol 2004 83 631 645 10.1078/0171-9335-00435 15679108 (Pubitemid 40123828)
54. A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures. Muffler S, Stark HJ, Amoros M, Falkowska-Hansen B, Boehnke K, Buhring HJ, Marme A, Bickenbach JR, Boukamp P, Stem Cells 2008 26 2506 2515 10.1634/stemcells.2007-0991 18653773
55. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M, Physiol Rev 2006 86 1309 1379 10.1152/physrev.00026.2005 17015491 (Pubitemid 44523706)
56. Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Wang A, Tang Z, Li X, Jiang Y, Tsou DA, Li S, Cells Tissues Organs 2012 195 5 14 10.1159/000331412 22005509
57. Improvement of nerve regeneration in tissue-engineered skin enriched with schwann cells. Blais M, Grenier M, Berthod F, J Invest Dermatol 2009 129 2895 2900 10.1038/jid.2009.159 19587695
58. Strategies for the assessment of acute skin irritation potential. Robinson MK, Osborne R, Perkins MA, J Pharmacol Toxicol Methods 1999 42 1 9 10.1016/S1056-8719(99)00037-4 10715598 (Pubitemid 30129121)
59. Development and validation of human psoriatic skin equivalents. Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, Schalkwijk J, Am J Pathol 2008 173 815 823 10.2353/ajpath.2008.080173 18669614
60. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. Friedmann PS, Gilchrest BA, J Cell Physiol 1987 133 88 94 10.1002/jcp.1041330111 2822734 (Pubitemid 18022450)
61. In vitro irritation models and immune reactions. Gibbs S, Skin Pharmacol Physiol 2009 22 103 113 10.1159/000178869 19188758
62. The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease-1990 update. Nickoloff BJ, Griffiths CE, Barker JN, J Invest Dermatol 1990 94 151S 157S 10.1111/1523-1747.ep12876134 2191050 (Pubitemid 20213085)
63. Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair follicle growth. Higgins CA, Chen JC, Cerise JC, Jahoda CA, Christiano AM, Proc Natl Acad Sci USA 2013 110 19679 19688 10.1073/pnas.1309970110 24145441
64. Induction of hair growth by implantation of cultured dermal papilla cells. Jahoda CA, Horne KA, Oliver RF, Nature 1984 311 560 562 10.1038/311560a0 6482967 (Pubitemid 14046378)
65. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M, Sadelain M, Nat Biotechnol 2013 31 928 933 10.1038/nbt.2678 23934177
66. Human skin cells support thymus-independent T cell development. Clark RA, Yamanaka K, Bai M, Dowgiert R, Kupper TS, J Clin Invest 2005 115 3239 3249 10.1172/JCI24731 16224538 (Pubitemid 41567588)
67. An organotypic coculture model supporting proliferation and differentiation of medullary thymic epithelial cells and promiscuous gene expression. Pinto S, Schmidt K, Egle S, Stark HJ, Boukamp P, Kyewski B, J Immunol 2013 190 1085 1093 10.4049/jimmunol.1201843 23269248